| . | Group A (N = 18) . | Group B (N = 19) . | P-value . |
|---|---|---|---|
| Gender | |||
| Male | 9 (50%) | 16 (84 %) | 0.038 |
| Female | 9 (50%) | 3 (16 %) | |
| Mean age (year) | 65 (±12) | 68 (±9) | 0.54 |
| BMI (kg/m2) | 28.3 (±3.7) | 27.8 (±2.8) | 0.64 |
| Nicotine | 7 (39%) | 4 (21%) | 0.29 |
| COPD (GOLD >2) | 11 (61%) | 15 (79%) | 0.29 |
| Kidney failure | 5 (28%) | 3 (16%) | 0.45 |
| PAD | 8 (44%) | 9 (47%) | 1.00 |
| DM insulin | 8 (44%) | 7 (37%) | 0.74 |
| LV ejection fraction | |||
| <30% | 2 | 0 | 0.51 |
| 30–50% | 7 | 9 | |
| >50% | 9 | 10 | |
| CABG | 17 (94%) | 17 (90%) | 1.00 |
| IMA | 17 (94%) | 15 (79%) | 0.33 |
| BIMA | 10 (55.5%) | 0 | 0.0001 |
| Other cardiac procedure | 1 (6%) | 2 (11%) | 1.00 |
| CPB time (min) | 82 (±54) | 116 (±45) | 0.046 |
| Operation time | 216 (±62) | 209 (±70) | 0.72 |
| Use of bone wax | 16 (89%) | 14 (74%) | 0.40 |
| Log EuroSCORE (%) | 8.8 (±5) | 10 (±7.9) | 0.58 |
| ICU stay (days) | 3.7 (±3.4) | 8.2 (±7.2) | 0.021 |
| Postop complications | |||
| Pulmonary infection | 3 (17%) | 4 (21%) | 1.00 |
| Delirium | 3 (17%) | 5 (26%) | 0.69 |
| Sternal infection | 6 (33%) | 9 (47%) | 0.51 |
| Time to diagnosis of SCF (weeks) | 25 (±10) | 27 (±17) | 0.69 |
| Primary SCF | 12 (67%) | 15 (79%) | 0.48 |
| Secondary SCF | 6 (33%) | 4 (21%) | |
| . | Group A (N = 18) . | Group B (N = 19) . | P-value . |
|---|---|---|---|
| Gender | |||
| Male | 9 (50%) | 16 (84 %) | 0.038 |
| Female | 9 (50%) | 3 (16 %) | |
| Mean age (year) | 65 (±12) | 68 (±9) | 0.54 |
| BMI (kg/m2) | 28.3 (±3.7) | 27.8 (±2.8) | 0.64 |
| Nicotine | 7 (39%) | 4 (21%) | 0.29 |
| COPD (GOLD >2) | 11 (61%) | 15 (79%) | 0.29 |
| Kidney failure | 5 (28%) | 3 (16%) | 0.45 |
| PAD | 8 (44%) | 9 (47%) | 1.00 |
| DM insulin | 8 (44%) | 7 (37%) | 0.74 |
| LV ejection fraction | |||
| <30% | 2 | 0 | 0.51 |
| 30–50% | 7 | 9 | |
| >50% | 9 | 10 | |
| CABG | 17 (94%) | 17 (90%) | 1.00 |
| IMA | 17 (94%) | 15 (79%) | 0.33 |
| BIMA | 10 (55.5%) | 0 | 0.0001 |
| Other cardiac procedure | 1 (6%) | 2 (11%) | 1.00 |
| CPB time (min) | 82 (±54) | 116 (±45) | 0.046 |
| Operation time | 216 (±62) | 209 (±70) | 0.72 |
| Use of bone wax | 16 (89%) | 14 (74%) | 0.40 |
| Log EuroSCORE (%) | 8.8 (±5) | 10 (±7.9) | 0.58 |
| ICU stay (days) | 3.7 (±3.4) | 8.2 (±7.2) | 0.021 |
| Postop complications | |||
| Pulmonary infection | 3 (17%) | 4 (21%) | 1.00 |
| Delirium | 3 (17%) | 5 (26%) | 0.69 |
| Sternal infection | 6 (33%) | 9 (47%) | 0.51 |
| Time to diagnosis of SCF (weeks) | 25 (±10) | 27 (±17) | 0.69 |
| Primary SCF | 12 (67%) | 15 (79%) | 0.48 |
| Secondary SCF | 6 (33%) | 4 (21%) | |
Bold values indicates statistically significant.
BMI: body mass index; LV: left ventricle; CABG: coronary artery bypass graft; SCF: sternocutaneous fistula; PAD: peripheral artery disease; DM: diabetes mellitus; IMA: internal mammary artery; BIMA: bilateral internal mammary artery.
| . | Group A (N = 18) . | Group B (N = 19) . | P-value . |
|---|---|---|---|
| Gender | |||
| Male | 9 (50%) | 16 (84 %) | 0.038 |
| Female | 9 (50%) | 3 (16 %) | |
| Mean age (year) | 65 (±12) | 68 (±9) | 0.54 |
| BMI (kg/m2) | 28.3 (±3.7) | 27.8 (±2.8) | 0.64 |
| Nicotine | 7 (39%) | 4 (21%) | 0.29 |
| COPD (GOLD >2) | 11 (61%) | 15 (79%) | 0.29 |
| Kidney failure | 5 (28%) | 3 (16%) | 0.45 |
| PAD | 8 (44%) | 9 (47%) | 1.00 |
| DM insulin | 8 (44%) | 7 (37%) | 0.74 |
| LV ejection fraction | |||
| <30% | 2 | 0 | 0.51 |
| 30–50% | 7 | 9 | |
| >50% | 9 | 10 | |
| CABG | 17 (94%) | 17 (90%) | 1.00 |
| IMA | 17 (94%) | 15 (79%) | 0.33 |
| BIMA | 10 (55.5%) | 0 | 0.0001 |
| Other cardiac procedure | 1 (6%) | 2 (11%) | 1.00 |
| CPB time (min) | 82 (±54) | 116 (±45) | 0.046 |
| Operation time | 216 (±62) | 209 (±70) | 0.72 |
| Use of bone wax | 16 (89%) | 14 (74%) | 0.40 |
| Log EuroSCORE (%) | 8.8 (±5) | 10 (±7.9) | 0.58 |
| ICU stay (days) | 3.7 (±3.4) | 8.2 (±7.2) | 0.021 |
| Postop complications | |||
| Pulmonary infection | 3 (17%) | 4 (21%) | 1.00 |
| Delirium | 3 (17%) | 5 (26%) | 0.69 |
| Sternal infection | 6 (33%) | 9 (47%) | 0.51 |
| Time to diagnosis of SCF (weeks) | 25 (±10) | 27 (±17) | 0.69 |
| Primary SCF | 12 (67%) | 15 (79%) | 0.48 |
| Secondary SCF | 6 (33%) | 4 (21%) | |
| . | Group A (N = 18) . | Group B (N = 19) . | P-value . |
|---|---|---|---|
| Gender | |||
| Male | 9 (50%) | 16 (84 %) | 0.038 |
| Female | 9 (50%) | 3 (16 %) | |
| Mean age (year) | 65 (±12) | 68 (±9) | 0.54 |
| BMI (kg/m2) | 28.3 (±3.7) | 27.8 (±2.8) | 0.64 |
| Nicotine | 7 (39%) | 4 (21%) | 0.29 |
| COPD (GOLD >2) | 11 (61%) | 15 (79%) | 0.29 |
| Kidney failure | 5 (28%) | 3 (16%) | 0.45 |
| PAD | 8 (44%) | 9 (47%) | 1.00 |
| DM insulin | 8 (44%) | 7 (37%) | 0.74 |
| LV ejection fraction | |||
| <30% | 2 | 0 | 0.51 |
| 30–50% | 7 | 9 | |
| >50% | 9 | 10 | |
| CABG | 17 (94%) | 17 (90%) | 1.00 |
| IMA | 17 (94%) | 15 (79%) | 0.33 |
| BIMA | 10 (55.5%) | 0 | 0.0001 |
| Other cardiac procedure | 1 (6%) | 2 (11%) | 1.00 |
| CPB time (min) | 82 (±54) | 116 (±45) | 0.046 |
| Operation time | 216 (±62) | 209 (±70) | 0.72 |
| Use of bone wax | 16 (89%) | 14 (74%) | 0.40 |
| Log EuroSCORE (%) | 8.8 (±5) | 10 (±7.9) | 0.58 |
| ICU stay (days) | 3.7 (±3.4) | 8.2 (±7.2) | 0.021 |
| Postop complications | |||
| Pulmonary infection | 3 (17%) | 4 (21%) | 1.00 |
| Delirium | 3 (17%) | 5 (26%) | 0.69 |
| Sternal infection | 6 (33%) | 9 (47%) | 0.51 |
| Time to diagnosis of SCF (weeks) | 25 (±10) | 27 (±17) | 0.69 |
| Primary SCF | 12 (67%) | 15 (79%) | 0.48 |
| Secondary SCF | 6 (33%) | 4 (21%) | |
Bold values indicates statistically significant.
BMI: body mass index; LV: left ventricle; CABG: coronary artery bypass graft; SCF: sternocutaneous fistula; PAD: peripheral artery disease; DM: diabetes mellitus; IMA: internal mammary artery; BIMA: bilateral internal mammary artery.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
